Lantus SoloStar Insulin Pen 100 Units/mL 3mL

Lantus SoloStar is a pre-filled disposable insulin pen containing insulin glargine 100 units/mL, a long-acting insulin analogue used in the management of diabetes mellitus when insulin treatment is required. Sanofi's current prescribing information identifies Lantus as a long-acting insulin analogue administered subcutaneously once daily, with the dose and timing individualized for each patient. Each SoloStar pen contains 3mL of solution, equivalent to 300 units of insulin glargine at a concentration of 100 units/mL. The pre-filled pen provides a convenient insulin-delivery format and is intended for subcutaneous administration. Lantus should be used strictly according to a healthcare professional's prescription and instructions. Insulin requirements vary between individuals and should not be determined from marketplace information. Key Features Contains insulin glargine Long-acting insulin analogue Strength: 100 units/mL 3mL pre-filled SoloStar pen Contains 300 units per pen Ready-to-use disposable pen format Solution for subcutaneous injection Once-daily administration according to prescription Dose and timing are individually determined Manufactured by Sanofi Designed for diabetes mellitus requiring insulin treatment Technical Specifications Specification Details Product Name Lantus SoloStar Generic Name Insulin Glargine Manufacturer Sanofi Pharmacological Class Long-acting insulin analogue Form Solution for injection Concentration 100 units/mL Pen Capacity 3mL Total Insulin per Pen 300 units Delivery System SoloStar pre-filled disposable pen Administration Subcutaneous injection Dosing Frequency Once daily as prescribed Solution Appearance Clear colourless solution Prescription Status Prescription medicine Primary Application Management of diabetes mellitus requiring insulin